High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.
about
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease riskMetabolic shifts due to long-term caloric restriction revealed in nonhuman primatesMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseEffect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysisSerum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseThe role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.The Effects of Very-Low-Calorie Diets on HDL: A ReviewCombinations of biomarkers predictive of later life mortality.High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease.Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO.Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.The role of endocannabinoid system blockade in the treatment of the metabolic syndrome.Present-day uses of niacin: effects on lipid and non-lipid parameters.Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease.Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.Ten-Year Survival in 75-Year-Old Men and Women: Predictive Ability of Total Cholesterol, HDL-C, and LDL-CSage tea drinking improves lipid profile and antioxidant defences in humans.Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.Antidiabetic Effects of Tea.Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats.Simultaneous determination of lovastatin and niacin in tablet by first and third derivative spectrophotometry and H-point standard addition methodsBMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people.Vegetarian diet and cholesterol and TAG levels by gender.HDL-cholesterol and physical performance: results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study).Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging.High-density lipoprotein cholesterol affects early endothelial progenitor cell number and endothelial function in obese women.Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
P2860
Q24646274-CDA8D029-708C-4FAD-9804-066FA9B081ABQ24647414-613417C4-A4D9-4802-A7E0-91896488DBFDQ28075372-4D460FFF-45D6-4A7E-B74C-2900C2574B09Q33663474-0B845927-DF88-4DEB-8084-D8ED6BED30FCQ34458822-EEE4BD70-5DB9-48AA-BA0F-B851C01261BDQ34730815-EA9A5113-B7D7-4816-B134-E3531B06E1FFQ34730842-2F6B21F6-11F5-44AC-826E-48EF71C36A4AQ35080505-91C5B098-91E9-4610-8A6B-4E56C9C1D709Q36539475-50DA3B10-43E5-473D-81F4-59C21C4E067AQ36553833-1CAE9711-5A73-488E-BE59-BE2D362B568BQ36752063-A79ACB37-7BF4-487D-964B-12D47AF0949CQ36766976-D1DD0EDA-9C77-48C2-97B6-338ED4438522Q36773310-E00E8CB2-1923-4CBC-A0AC-E0FA9A0D80B1Q36904907-5841EDB1-985E-46CE-A1C6-342C4DA4D60CQ36992708-8CB0A09E-1576-45CD-AB4C-54783648104FQ37040733-AA9DE6C6-5E5D-4EBB-BFBD-D58DC2064D48Q37172825-A36AA51F-CD15-4942-8E2D-1F566E39B9A2Q37403039-272A932C-800E-4B91-8949-4C18AAF8D258Q37953462-B9371EC3-138E-498A-A92F-EF54E60757B6Q38776117-F525F745-32FC-4396-9A47-6A180EF03461Q39322313-1A575358-7BD4-4500-A9FD-A49AFA7C9393Q40334010-9224BE4E-56C8-4CE9-978E-C8F44596E0C7Q41540945-6C7D2C79-7D30-4A9C-941A-64816414D0C3Q42371605-46FE98C1-76C1-4068-A6A8-88320BEDC8F8Q45947242-244C4EB4-D78C-4525-96A6-0EC84F9DD165Q46968845-5CB08D81-9E03-40D9-AB83-6D5ED52BC897Q47241309-B551172C-4218-4BAD-A465-3A6D9B184B09Q48024855-301BD495-987E-43B1-A63A-288495B6FFC0Q51260780-40BC44B4-9752-4664-8725-754D37E0BF79Q52640082-0582FB33-5A8E-4D08-8551-433A41703280
P2860
High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
High-density lipoprotein as a ...... ence and treatment strategies.
@ast
High-density lipoprotein as a ...... ence and treatment strategies.
@en
type
label
High-density lipoprotein as a ...... ence and treatment strategies.
@ast
High-density lipoprotein as a ...... ence and treatment strategies.
@en
prefLabel
High-density lipoprotein as a ...... ence and treatment strategies.
@ast
High-density lipoprotein as a ...... ence and treatment strategies.
@en
P1476
High-density lipoprotein as a ...... ence and treatment strategies.
@en
P2093
Peter P Toth
P304
50K-58K; discussion 34K-35K
P356
10.1016/J.AMJCARD.2005.08.008
P407
P577
2005-09-15T00:00:00Z